<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01514045</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-20285</org_study_id>
    <secondary_id>SU-01172012-8987</secondary_id>
    <secondary_id>GI0005</secondary_id>
    <nct_id>NCT01514045</nct_id>
  </id_info>
  <brief_title>The Gastric Cancer Foundation: A Gastric Cancer Registry</brief_title>
  <official_title>The Gastric Cancer Foundation: A Gastric Cancer Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Gastric Cancer Registry will combine data acquired directly from patients with gastric&#xD;
      cancer; with a family history of gastric cancer in a first or second degree relative; or&#xD;
      persons with a known germline mutation in their CDH1 (E-Cadherin) gene via an online&#xD;
      questionnaire with genomic data obtained from saliva, blood and tissue samples. The purpose&#xD;
      of this registry is to gain better understanding of the causes of gastric cancer, both&#xD;
      environmental and genetic; whether certain genomic data can predict outcomes of treatment and&#xD;
      survival.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Collect detailed clinical and epidemiological information on eligible patients via an online&#xD;
      registry and a detailed patient questionnaire. Participants can opt in to contribute a blood&#xD;
      or saliva sample and paraffin block samples from a previous gastric surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Collect detailed clinical and epidemiological information on patients with gastric cancer; with a family history of gastric cancer in a first or second degree relative; or persons with a known germline mutation in their CDH1 (E-Cadherin) gene</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Gastric Cancer</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples with DNA Paraffin embedded tissue will be stored in the Stanford Tissue Bank&#xD;
      for 100 years.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participants will be identified for recruitment either by the individual's treating&#xD;
        physician or through information about the registry on the Gastric Cancer Fund website.&#xD;
        Potential participants will be directed to the URL for the gastric cancer registry and&#xD;
        asked to complete a brief registration form which will include eligibility questions.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients are eligible if they have a histologically proven gastric tumor including&#xD;
             gastroesophageal tumors; OR they have a family history of gastric cancer in a first or&#xD;
             second degree relative; OR persons with a known germline mutation in their CDH1&#xD;
             (E-Cadherin) gene.&#xD;
&#xD;
          2. 18 years of age or older&#xD;
&#xD;
          3. Adequate English proficiency to complete online consent and questionnaire.&#xD;
             Spanish-language proficiency as an alternative to English-language proficiency.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Under 18 years of age&#xD;
&#xD;
          2. No history of gastric cancer or gastric cancer in a family member or a known germline&#xD;
             mutation in their CDH1 gene.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hanlee P Ji, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alison Almeda</last_name>
    <phone>650-497-3619</phone>
    <email>GCRegistry@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University, School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alison Almeda</last_name>
      <phone>650-497-3619</phone>
      <email>GCRegistry@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Hanlee P Ji, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 17, 2012</study_first_submitted>
  <study_first_submitted_qc>January 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 20, 2012</study_first_posted>
  <last_update_submitted>September 9, 2021</last_update_submitted>
  <last_update_submitted_qc>September 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Quality of Life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

